Latest TYBOURNE CAPITAL MANAGEMENT (HK) LTD Stock Portfolio
$30.93Million | No. of Holdings #4
About TYBOURNE CAPITAL MANAGEMENT (HK) LTD and 13F Hedge Fund Stock Holdings
On 2025-11-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, TYBOURNE CAPITAL MANAGEMENT (HK) LTD reported an equity portfolio of $30.9 Millions as of 30 Sep, 2025. <br><br> The top stock holdings of TYBOURNE CAPITAL MANAGEMENT (HK) LTD are TSHA, FBRX, . The fund has invested 39.1% of it's portfolio in TAYSHA GENE THERAPIES INC (TSHA US) and 38.1% of portfolio in FORTE BIOSCIENCES INC (FBRX US). <br><br> The fund managers got completely rid off BICYCLE THERAPEUTICS LTD-ADR (BCYC US) (BCYC) and MALIBU BOATS INC (MBUU US) (MBUU) stocks. They significantly reduced their stock positions in ZENTALIS PHARMACEUTICALS INC (ZNTL US) (ZNTL) and TAYSHA GENE THERAPIES INC (TSHA US) (TSHA).
TYBOURNE CAPITAL MANAGEMENT (HK) LTD Equity Portfolio Value
Last Reported on: 06 Nov, 2025
$30.93Million
as of Nov 06, 2025TYBOURNE CAPITAL MANAGEMENT (HK) LTD Annual Return Estimates Vs S&P 500
- Performance
New Buys
No new stocks were added by TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Additions
No additions were made to existing positions by TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Reductions
| Ticker | % Reduced |
|---|---|
| zentalis pharmaceuticals inc (zntl us) | -34.95 |
| taysha gene therapies inc (tsha us) | -9.65 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| bicycle therapeutics ltd-adr (bcyc us) | -6,906,510 |
| malibu boats inc (mbuu us) | -2,090,540 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD got rid off the above stocks
Sector Distribution
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 82 |
| Others | 18 |
Market Cap. Distribution
- SMALL-CAP
- NANO-CAP
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 39.1 |
| NANO-CAP | 38.1 |
| UNALLOCATED | 18 |
| MICRO-CAP | 4.7 |
Stocks belong to which Index?
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 95.3 |
| RUSSELL 2000 | 4.7 |
| Top 5 Losers (%) | % | |
|---|---|---|
| Top 5 Losers ($) | $ | |
|---|---|---|
TYBOURNE CAPITAL MANAGEMENT (HK) LTD Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of TYBOURNE CAPITAL MANAGEMENT (HK) LTD
$30.93MTotal Value
6.00Positions
06 Nov, 2025Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Bicycle Therapeutics Ltd-Adr (Bcyc Us) TYBOURNE CAPITAL MANAGEMENT (HK) LTD's holding in Bicycle Therapeutics Ltd-Adr (Bcyc Us) over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Forte Biosciences Inc (Fbrx Us) TYBOURNE CAPITAL MANAGEMENT (HK) LTD's holding in Forte Biosciences Inc (Fbrx Us) over time | 38.15% | 786,647 | $11.80M 38.15% | 0%unchanged 0 percentunchanged | |
 Malibu Boats Inc (Mbuu Us) TYBOURNE CAPITAL MANAGEMENT (HK) LTD's holding in Malibu Boats Inc (Mbuu Us) over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Taysha Gene Therapies Inc (Tsha Us) TYBOURNE CAPITAL MANAGEMENT (HK) LTD's holding in Taysha Gene Therapies Inc (Tsha Us) over time | 39.11% | 3,700,000 | $12.10M 39.11% | 9.65%decreased 9.65 percentreduced | |
 Zentalis Pharmaceuticals Inc (Zntl Us) TYBOURNE CAPITAL MANAGEMENT (HK) LTD's holding in Zentalis Pharmaceuticals Inc (Zntl Us) over time | 4.69% | 961,486 | $1.45M 4.69% | 34.95%decreased 34.95 percentreduced | |
Com Alumis Inc (Alms Us)Alumis Inc (Alms Us) | 18.05% | 1,399,250 | $5.58M 18.05% | 0%unchanged 0 percentunchanged | |